patent_id,patent_date,patent_title,patent_num_times_cited_by_us_patents,cpc_subclass_ids
12422438,2025-09-23,Means and methods for single molecule peptide sequencing,0,C12N|G01N
12419972,2025-09-23,Muscle-specific nucleic acid regulatory elements and methods and use thereof,0,A61K|A61P|C12N
12419844,2025-09-23,Composition for treatment of vitreous disease or disorder,0,A61F|A61K|B82Y
12410225,2025-09-09,Modulation of dendritic cell lineages,0,A61K|A61P|C07K
12410222,2025-09-09,Fusokines involving cytokines with strongly reduced receptor binding affinities,0,A61K|A61P|C07K
12409236,2025-09-09,Liver-specific nucleic acid regulatory elements and methods and use thereof,0,A61K|A61P|C07K|C12N|C12Y
12392714,2025-08-19,Optical alignment compensation system for a gas detection system,0,G01N
12385813,2025-08-12,Electron microscopy grids and high-resolution structural determination methods,0,G01N|H01J
12383628,2025-08-12,Hydrogel-forming composition for controlled release,0,A61K|A61P
12364753,2025-07-22,CD8 binding agents,0,A61K|A61P|C07K|Y02A
12285018,2025-04-29,Plant growth promoting microbial compositions,0,A01N|C12N|C12R
12259361,2025-03-25,System and method for photoacoustic inspection of an object,0,G01N
12251443,2025-03-18,Drug formulations comprising polyoxazolines as matrix excipient,0,A61K|C08G|C08L
12241108,2025-03-04,Genetically engineered eukaryotic cells producing LacNAc-glycoproteins,0,A61K|C07K|C12N|C12P|C12Y
12227550,2025-02-18,Targeted modified TNF family members,0,A61K|A61P|C07K
12226503,2025-02-18,Prebiotic skin care compositions containing carboxylic acids,0,A61K|A61Q
12188941,2025-01-07,Use of bacterial extracellular vesicles as a biomarker for intestinal barrier permeability and microbial dysbiosis,0,C12Q|G01N
12171811,2024-12-24,Compositions for use to treat advanced glycation end products-dependent ocular diseases,0,A61K|A61P|C12N|C12Y
12163138,2024-12-10,Mutant plant cinnamoyl-CoA reductase proteins,0,A01H|C12N|C12Y
12123041,2024-10-22,Method for the production of amino sugar-containing products,0,C12N|C12P|C12Y
12110527,2024-10-08,Production of symmetrical bolaform sophorosides,0,C12N|C12P|C12Y
12105091,2024-10-01,Usages of recombinant extracellular vesicles,0,C07K|C12Q|G01N
12091655,2024-09-17,Method to selectively permeabilize and/or fragmentize cells,0,A61B|A61F|C12M|C12N
12037456,2024-07-16,Poly(2-oxazoline)s and methods for preparing them,0,A61K|A61L|C08G|C08L
12029552,2024-07-09,Direct infrared analysis of post-translational modification of proteins,0,A61B|G01N
12019076,2024-06-25,Means and methods for single molecule peptide sequencing,1,C12N|G01N
11975078,2024-05-07,Muscle-specific nucleic acid regulatory elements and methods and use thereof,1,A61K|A61P|C12N
11964002,2024-04-23,Means and methods for oral protein delivery,0,A23K|A23L|A23V|A61K|A61P|C07K|C12N|C12P
11939586,2024-03-26,Means and methods for improved regeneration,0,C07K|C12N
11920292,2024-03-05,Methods for obtaining colored or chromic substrates,0,C08J|C09B|C09K|D06P|D10B|G01N
11891451,2024-02-06,Glycosylation of variable immunoglobulin domains,0,A61K|C07K
11793878,2023-10-24,Drug formulations comprising polyoxazolines as matrix excipient,0,A61K|C08G|C08L
11786476,2023-10-17,Oral dosage form,0,A61K
11761884,2023-09-19,Photoacoustic transducer,0,G01N
11740229,2023-08-29,Method and system for determining biomarker concentration,0,G01N
11725212,2023-08-15,Polynucleotide shuffling method,0,C12N|C12Q
11713354,2023-08-01,Galectin-10 antibodies,0,A61K|A61P|C07K|G01N
11712484,2023-08-01,Carbon-based particles for vapour bubble generation,0,A61K|A61P|B82Y|C01B|G10K
11702477,2023-07-18,Bi-functional chimeric proteins and uses thereof,0,A61P|C07K|C12N
11661455,2023-05-30,Chimeric protein comprising an interferon alpha 2mutant and a PD-L1 binding moiety,1,A61K|A61P|C07K
11654201,2023-05-23,Liver-specific nucleic acid regulatory elements and methods and use thereof,0,A61K|A61P|C07K|C12N|C12Y
11633440,2023-04-25,Use of microbial communities for human and animal health,0,A23L|A23V|A61K|A61P|C12N|Y02A
11608326,2023-03-21,Synthetic receptors for ionophoric compounds,0,A61P|B01J|C07D
11596658,2023-03-07,Use of microbial communities for human and animal health,0,A23L|A23V|A61K|A61P|C12N|Y02A
11573238,2023-02-07,Means and methods for single molecule peptide sequencing,9,C12N|G01N
11491196,2022-11-08,Use of microbial communities for human and animal health,0,A23L|A23V|A61K|A61P|C12N|Y02A
11478499,2022-10-25,Compositions for use to treat cataract,0,A61K|A61P|C12Y
11475683,2022-10-18,Object classification system and method,0,G01N|G02B|G06N|G06V|H04N
11421209,2022-08-23,Cells producing Fc containing molecules having altered glycosylation patterns and methods and use thereof,0,C07K|C12N|C12P|C12Y
11397186,2022-07-26,Methods for covalently binding a cell surface protein and a ligand,0,G01N
11396532,2022-07-26,Targeted modified TNF family members,0,A61K|A61P|C07K
11384154,2022-07-12,Targeted chimeric proteins and uses thereof,1,A61K|A61P|C07K
11358997,2022-06-14,Fusokines involving cytokines with strongly reduced receptor binding affinities,1,A61K|A61P|C07K
11357853,2022-06-14,Inhibition of a lncRNA for treatment of neuroblastoma,0,A61K|A61P|C12N|C12Q|G01N
11339124,2022-05-24,3-(benzylamino)-4-(cyclohexylamino)-n-(2-(piperazin-1-yl)ethyl)benzenesulfonamide derivatives and related ferrostatin-1 analogues as cell death inhibitors for treating e.g. stroke,1,A61K|A61P|C07C|C07D
11298057,2022-04-12,Tunable hybrid III-V/IV laser sensor system-on-a-chip for real-time monitoring of a blood constituent concentration level,2,A61B|G01J|G01N|H01S
11293872,2022-04-05,Laser ablation probe,0,G01N|H01J
11293138,2022-04-05,Methods for obtaining colored or chromic substrates,1,C08J|C09B|C09K|D06P|D10B|G01N
11293012,2022-04-05,Cells producing glycoproteins having altered N- and O-glycosylation patterns and methods and use thereof,0,C07K|C12N|C12P|C12Y
11248057,2022-02-15,CD20 binding single domain antibodies,2,A61K|A61P|C07K
11246911,2022-02-15,Immune-cell targeted bispecific chimeric proteins and uses thereof,3,A61K|C07K|Y02A
11242511,2022-02-08,"Cytoplasmic protein complex comprising a kinase substrate sensor, cells comprising the complex, and associated detection methods",0,C07K|C12N|C12Q|G01N
11241474,2022-02-08,Prebiotic oral care compositions containing amino acids,0,A61K|A61P|A61Q
11237174,2022-02-01,Method for detecting protein-protein interactions in a cell utilizing particle-forming polypeptide-bait fusion proteins and virus-like particles,0,C07K|C12N|G01N
11236166,2022-02-01,CD8 binding agents,6,A61K|A61P|C07K|Y02A
11236141,2022-02-01,Targeted mutant interferon-beta and uses thereof,3,A61K|A61P|C07K|C12N|Y02A
11231416,2022-01-25,Virus-like particle (VLP) based small molecule-protein interaction trap,0,C07K|C12N|G01N
11213815,2022-01-04,Netwell assay plate system,0,B01L|C12Q
11213573,2022-01-04,Particles comprising surfactant protein B and one or more lipids,0,A61K|A61P|C07K
11208667,2021-12-28,Means and methods for regulating secondary metabolite production in plants,0,C07K|C12N
11193136,2021-12-07,Cellulose synthase inhibitors and mutant plants,0,A01N|C12N
11192977,2021-12-07,Use of poly(alkylene terephthalates) and methods for their preparation,0,A61L|C08G|C12M|C12N
11181527,2021-11-23,Means and methods for monitoring inflammation,0,G01N
11098337,2021-08-24,Cells producing glycoproteins having altered glycosylation patterns and method and use thereof,0,C07K|C12N|C12P|C12Y
11084859,2021-08-10,Targeted mutant interferon-gamma and uses thereof,4,A61K|A61P|C07K|Y02A
11083751,2021-08-10,Tumor-associated dendritic cell preparations and uses thereof,0,A61K|A61P|C12N
11072801,2021-07-27,Muscle-specific nucleic acid regulatory elements and methods and use thereof,1,A61K|A61P|C12N
11066473,2021-07-20,Galectin-10 antibodies,1,A61K|A61P|C07K|G01N
11065207,2021-07-20,Oral dosage form,0,A61K
11053300,2021-07-06,Membrane span-kinase fusion protein and the uses thereof,0,C07K|C12N|C12Q|C12Y|G01N
11053279,2021-07-06,Methods for the site-selective coupling of a first agent to a second agent,0,C07K
11033572,2021-06-15,Molecular adjuvants for enhanced cytosolic delivery of active agents,0,A61K
11001631,2021-05-11,Clec9A binding agents,5,A61K|A61P|C07K|Y02A
11001624,2021-05-11,TSLP inhibitors,0,A61K|A61P|C07K
10988538,2021-04-27,Bispecific signaling agents and uses thereof,4,A61K|A61P|C07K|Y02A
10983076,2021-04-20,Magnetic resonance spectroscopy water suppression method and device,0,G01N|G01R
10966928,2021-04-06,Oral dosage form,0,A61K
10947288,2021-03-16,Targeting of human interferon antagonists,3,A61P|C07K
10946077,2021-03-16,Cooperia vaccine,0,A61K|C07K
10946070,2021-03-16,Targeted and mutated human-interferon fusion proteins,3,A61K|A61P|C07K
10941418,2021-03-09,Means and methods for generating complex glycans derived from fungal engineered hosts,0,A61K|A61P|C12P|C12Y
